DiaMedica Therapeutics
DMAC
DMAC
34 hedge funds and large institutions have $11.2M invested in DiaMedica Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less call options, than puts
Call options by funds: $172K | Put options by funds: $465K
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
34
Holding in Top 10
–
Calls
$172K
Puts
$465K
Top Buyers
| 1 | +$602K | |
| 2 | +$298K | |
| 3 | +$272K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$137K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$82.1K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$1.02M | |
| 3 | -$906K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$694K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$581K |